Acquisition to expand Goldman Sachs-backed BPL Medical’s presence in critical care medical devices segment locally and globally
BPL Medical Technologies announced the acquisition of UK-based Penlon, a leading global manufacturer of anaesthesia systems and vaporisers with worldwide distribution networks. Penlon’s product range complements BPL Medical’s existing portfolio and will help in expanding its presence in the critical care segment. Penlon will continue to be based and operated from the UK under the leadership of the existing management team.
Penlon has its presence in 96 countries, including India. With a strong focus on product innovation and a leading position in developed and emerging markets, the company designs, engineers and manufactures anaesthesia systems, vaporisers and other complementary products. These products are sourced by hospitals, pharmaceutical companies and anaesthesia system manufacturers worldwide.
Sunil Khurana, CEO, BPL Medical said, “This acquisition will help us penetrate the large critical care segment in India with Penlon’s world-renowned, technology-driven an anaesthesia machines and vaporisers. BPL Medical will leverage Penlon’s R&D capabilities to develop many new products suitable for India and other emerging markets. Additionally, Penlon’s global reach will help expand BPL Medical’s international presence.”
Stephen Moon, CEO, Penlon, said, “This partnership secures a long term investment which underpins our product strategy to develop world class anaesthesia machines, monitors and next-generation vaporisers over the coming years. We now plan to expand our product development capabilities across the business and will bring forward a number of key projects. We will also benefit from BPL Medical’s strength in India which will provide substantial growth in the years to come.”
Comments are closed.